The Food and Drug Administration (FDA) announced that it is considering allowing the use of amphetamine-like drug fenfluramine to treat forms of epilepsy that are otherwise difficult to treat and resistant to traditional anti-epileptic drugs.
Amphetamine-like substances are banned in Taiwan, with the import, manufacture and sale of fenfluramine prohibited in 1980, when all licenses for its use were revoked, Medicinal Product Division deputy head Lin Yi-chu (林意筑) said today.
The FDA, under the Ministry of Health and Welfare (MOHW), on Tuesday announced draft revisions to the regulations on amphetamine-like substances and their derivatives, with a 14-day window for public comment.
Photo: Chung Li-hua, Taipei Times
Fenfluramine was previously used for weight loss, with many countries removing it from the market following clinical trials that showed it can cause side effects, including valvular heart disease, Lin said.
However, research has shown that controlled use of the drug is effective in treating Dravet Syndrome and Lennox-Gastaut Syndrome, rare forms of epilepsy otherwise difficult to treat, she said.
Since 2020, the US, Europe and Japan have gradually approved it for controlled use, she added.
Repeated seizures can hinder normal development and cause neurological impairments, leading to a higher mortality rate and impacting the quality of life of caregivers, she said.
Several organizations in Taiwan, including the Taiwan Foundation for Rare Disorders, the Taiwan Epilepsy Association and the Taiwan Child Neurology Society, have petitioned that the FDA approve the use of fenfluramine, she said.
After consulting medical societies and medical professionals, the FDA is considering approving fenfluramine and its salt to treat these two rare syndromes, she said.
Amphetamine-like drugs are central nervous system stimulants that may cause symptoms such as restlessness, dizziness, tremors, hyperactivity, insomnia, anxiety and delirium, the draft regulation said.
They are also addictive and can cause increased tolerance in patients, it said.
Amphetamine-like substances would still be strictly controlled under the Pharmaceutical Affairs Act (藥事法), including amphetamine, dexamphetamine, methamphetamine, phendimetrazine, diethylpropione and fenfluramine, it said.
Eight Chinese naval vessels and 24 military aircraft were detected crossing the median line of the Taiwan Strait between 6am yesterday and 6am today, the Ministry of National Defense said this morning. The aircraft entered Taiwan’s northern, central, southwestern and eastern air defense identification zones, the ministry said. The armed forces responded with mission aircraft, naval vessels and shore-based missile systems to closely monitor the situation, it added. Eight naval vessels, one official ship and 36 aircraft sorties were spotted in total, the ministry said.
The Ministry of Foreign Affairs (MOFA) today said that if South Korea does not reply appropriately to its request to correct Taiwan’s name on its e-Arrival card system before March 31, it would take corresponding measures to alter how South Korea is labeled on the online Taiwan Arrival Card system. South Korea’s e-Arrival card system lists Taiwan as “China (Taiwan)” in the “point of departure” and “next destination” fields. The ministry said that it changed the nationality for South Koreans on Taiwan’s Alien Resident Certificates from “Korea” to “South Korea” on March 1, in a gesture of goodwill and based on the
Taiwanese officials were shown the first of 66 F-16V fighter jets purchased by Taiwan from the United States, the Ministry of National Defense said yesterday, adding the aircraft has completed an initial flight test and is expected to be delivered later this year. A delegation led by Deputy Minister of National Defense Hsu Szu-chien (徐斯儉) visited Lockheed Martin’s F-16 C/D Block 70 (also known as F-16V) assembly line in South Carolina on March 16 to view the aircraft. The jet will undergo a final acceptance flight in the US before being delivered to Taiwan, the
The New Taipei Metro's Sanyin Line and the eastern extension of the Taipei Metro's Tamsui-Xinyi Line (Red Line) are scheduled to begin operations in June, the National Development Council said today. The Red Line, which terminates at Xiangshan Station, would be connected by the 1.4km extension to a new eastern terminal, Guangci/Fengtian Temple Station, while the Sanyin Line would link New Taipei City's Tucheng and Yingge stations via Sanxia District (三峽). The council gave the updates at a council meeting reviewing progress on public construction projects for this year. Taiwan's annual public infrastructure budget would remain at NT$800 billion (US$25.08 billion), with NT$97.3
RSS